Ethyl Acetate

Ethyl Acetate

SCHEMBL6492983

CCOC(=O)CCCO.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CCOC(C)=O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
HSD17B10 Q99714 2/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.55
CYP4F2 P78329 3/20 0.46
CYP4A11 Q02928 3/20 0.46
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
NR1I2 O75469 1/20 0.44
PGR P06401 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
PTGS2 P35354 1/20 0.44
PDE4D Q08499 1/20 0.44
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TRPA1 O75762 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL1238750 1.00 ALDH1A1 (0.58) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
Ethyl Acetate SCHEMBL6491161 1.00 ALDH1A1 (0.58) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
Ethyl Acetate SCHEMBL6528564 0.96 ALDH1A1 (0.54) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
Cyclohexane SCHEMBL5942479 0.94 ALDH1A1 (0.52) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
Ethyl Acetate SCHEMBL9280580 0.94 ALDH1A1 (0.56) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
SCHEMBL6736 0.91
Ethyl Acetate SCHEMBL4168022 0.91 DGKA (0.56) ALDH1A1HSD17B10LMNACYP1A2TSHR
Acetic Acid SCHEMBL1149338 0.89 CYP1A2 (0.57) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
Acetic Acid SCHEMBL989387 0.89 CYP1A2 (0.57) ALDH1A1HSD17B10LMNACYP1A2CYP4F2
Acetic Acid SCHEMBL5722467 0.89 CYP1A2 (0.57) ALDH1A1HSD17B10LMNACYP1A2CYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209230-A1 2-leaving group-4-(substituted amino)-5-fluoropyrimidines such as 2-chloro-N4-(2-hydroxyphenyl)-5-fluoro-4-pyrimidineamine; chemical intermediates to compounds that inhibit the immunoglobulin (Ig) IgE and/or IgG receptor signaling cascades MIDCAP FINANCIAL TRUST 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209230-A1 2-leaving group-4-(substituted amino)-5-fluoropyrimidines such as 2-chloro-N4-(2-hydroxyphenyl)-5-fluoro-4-pyrimidineamine; chemical intermediates to compounds that inhibit the immunoglobulin (Ig) IgE and/or IgG receptor signaling cascades FCER2, FCGR1A, FCGR2A ALDH1A1 2615/4885HSD17B10 4689/4885LMNA 4802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.